Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Neurology
ASCO 2025
Questions discussed in this category
What are your top takeaways in Neuro Oncology from ASCO 2025?
2 Answers available
24672
Papers discussed in this category
Neuro-oncology, 2013-10
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Related Topics in Neurology
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Non-malignant Disease
Pediatric Hematology/Oncology
